Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Other Working Capital Changes: 2011-2025

Historic Other Working Capital Changes for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to $379,000.

  • Enanta Pharmaceuticals' Other Working Capital Changes fell 155.06% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $903,000, marking a year-over-year decrease of 81.92%. This contributed to the annual value of $379,000 for FY2025, which is 92.41% down from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Other Working Capital Changes stood at $379,000 for FY2025, which was down 92.41% from $5.0 million recorded in FY2024.
  • Over the past 5 years, Enanta Pharmaceuticals' Other Working Capital Changes peaked at $5.0 million during FY2024, and registered a low of -$5.9 million during FY2021.
  • For the 3-year period, Enanta Pharmaceuticals' Other Working Capital Changes averaged around $935,333, with its median value being $379,000 (2025).
  • In the last 5 years, Enanta Pharmaceuticals' Other Working Capital Changes plummeted by 180.87% in 2021 and then surged by 294.55% in 2024.
  • Over the past 5 years, Enanta Pharmaceuticals' Other Working Capital Changes (Yearly) stood at -$5.9 million in 2021, then spiked by 36.96% to -$3.7 million in 2022, then spiked by 30.73% to -$2.6 million in 2023, then spiked by 294.55% to $5.0 million in 2024, then plummeted by 92.41% to $379,000 in 2025.